Goat Polyclonal ILF1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human FOXK2 aa 600 to C-terminus.
View Alternative Names
ILF, ILF1, FOXK2, Forkhead box protein K2, G/T-mismatch specific binding protein, Interleukin enhancer-binding factor 1, nGTBP
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ILF1 antibody (AB5298)
Immunofluorescent analysis of paraformaldehyde fixed HeLa cells, labeling ILF-1 with ab5298. Cells permeabilized with 0.15% Triton. Primary incubation 1hr (10 μg/mL) followed by Alexa Fluor 488 secondary antibody (2 μg/mL), showing nuclear and cytoplasmic/vesicle staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control : Unimmunized goat IgG (10 μg/mL) followed by Alexa Fluor 488 secondary antibody (2 μg/mL).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-ILF1 antibody (AB5298)
Flow cytometric analysis of paraformaldehyde fixed HeLa cells (blue line) labeling ILF1 with ab5298. Cells permeabilized with 0.5% Triton. Primary incubation 1hr (10 μg/mL) followed by Alexa Fluor 488 secondary antibody (1 μg/mL). IgG control : Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-ILF1 antibody (AB5298)
Immunofluorescent analysis of paraformaldehyde fixed U2OS cells, labeling ILF-1 with ab5298. Cells permeabilized with 0.15% Triton. Primary incubation 1hr (10 μg/mL) followed by Alexa Fluor 488 secondary antibody (2 μg/mL), showing nuclear and cytoplasmic/vesicle staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control : Unimmunized goat IgG (10 μg/mL) followed by Alexa Fluor 488 secondary antibody (2 μg/mL).
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-ILF1 antibody (AB5298)
Immunofluorescence analysis of U2OS cells, staining ILF1 with ab5298. Cells were fixed with 4% paraformaldehyde and incubated with primary antibody at 1/100 dilution. A FITC-conjugated rabbit anti-goat IgG was used as the secondary antibody.
Image from Marais A et al., J Biol Chem. 2010 Nov 12;285(46):35728-39. Epub 2010 Sep 1. Fig 2.; doi: 10.1074/jbc.M110.154005; November 12, 2010, The Journal of Biological Chemistry, 285, 35728-35739.
- WB
Supplier Data
Western blot - Anti-ILF1 antibody (AB5298)
All lanes:
Western blot - Anti-ILF1 antibody (ab5298) at 0.03 µg/mL
Lane 1:
HEK-293 (human epithelial cell line from embryonic kidney) nuclear cell lysate at 35 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) nuclear cell lysate at 35 µg
Lane 3:
Jurkat (human T cell leukemia cell line from peripheral blood) nuclear cell lysate at 35 µg
Predicted band size: 69 kDa
Observed band size: 80 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ILF1 influences several cellular processes related to RNA dynamics by engaging in RNA splicing export and translation regulation. It doesn't function alone but rather forms complexes with other proteins such as the nuclear factor 45 (NF45). Through these interactions ILF1 contributes actively to cellular stress responses influencing protein synthesis under stress conditions and aiding in regulating cytokine production.
Pathways
ILF1 intricately integrates into cellular pathways like the NF-κB signaling pathway and the T-cell receptor signaling pathway. In these contexts it interacts with proteins such as IκB kinase (IKK) and T-cell receptor-associated proteins playing a part in transcriptional regulation and immune response modulation. ILF1's involvement in these pathways highlights its importance in cellular adaptation and survival in response to external stressors and pathogens.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Cancer letters 597:217074 PubMed38901667
2024
Applications
Unspecified application
Species
Unspecified reactive species
Oncogene 43:1985-1999 PubMed38734828
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 17:2294-2307 PubMed34239356
2021
Applications
Unspecified application
Species
Unspecified reactive species
Protein & cell 12:557-577 PubMed32683582
2020
Applications
Unspecified application
Species
Unspecified reactive species
Oncogenesis 7:29 PubMed29540677
2018
Applications
Unspecified application
Species
Unspecified reactive species
International journal of cancer 142:2543-2557 PubMed29368368
2018
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 5:8796 PubMed25740706
2015
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 42:6232-42 PubMed24748658
2014
Applications
IP
Species
Unspecified reactive species
Molecular and cellular biology 32:385-98 PubMed22083952
2011
Applications
WB, ChIP
Species
Human, Human
The Journal of biological chemistry 285:35728-39 PubMed20810654
2010
Applications
WB, ICC/IF
Species
Human, Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com